The Efficacy and Safety of D745 Added to D150 Plus D759 Therapy in Patients with Type 2 Diabetes

NCT05566028 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

172

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: D745 formulation I
DRUG: D745 formulation II
DRUG: D745 Placebo

Sponsor

Chong Kun Dang Pharmaceutical